Rapid, simple, and cost-effective plaque assay for murine norovirus using microcrystalline cellulose. 2023

Soh Yamamoto, and Yuka Sudo-Yokoyama, and Noriko Ogasawara, and Shin-Ichi Yokota
Department of Microbiology, Sapporo Medical University School of Medicine, Sapporo, Japan.

Murine norovirus (MNV) is used widely as a practical alternative to human norovirus (HuNoV). Plaque-forming assays for MNV are important for developing therapeutic agents against HuNoV infections. Although agarose-overlay MNV assays have been reported, recent improvements in cellulose derivatives suggest that they could be optimized further, particularly with respect to improving the overlay material. To determine which overlay material is optimal for the MNV plaque assay, we compared four typical cellulose derivatives [microcrystalline cellulose (MCC), hydroxyethyl cellulose (HEC), hydroxypropyl methylcellulose (HPMC), and carboxymethyl cellulose (CMC)] with conventional agarose. We found that 3.5% (w/v) MCC-containing medium provided clear round-shaped plaques on RAW 264.7 cells 1 day after inoculation; the visibility of plaques was comparable with that of the original agarose-overlay assay. Removing residual MCC powder from the MCC-overlay assay before fixing was important for obtaining distinct plaques that are clearly countable. Finally, after calculating the plaque diameter as a percentage of well diameter, we found that 12- and 24-well plates were better than other plates for accurate plaque counting. The MCC-based MNV plaque assay is cost-effective and rapid, and produces plaques that are easy to count. Accurate virus quantification using this optimized plaque assay will enable reliable estimation of norovirus titers.

UI MeSH Term Description Entries
D010948 Viral Plaque Assay Method for measuring viral infectivity and multiplication in CULTURED CELLS. Clear lysed areas or plaques develop as the VIRAL PARTICLES are released from the infected cells during incubation. With some VIRUSES, the cells are killed by a cytopathic effect; with others, the infected cells are not killed but can be detected by their hemadsorptive ability. Sometimes the plaque cells contain VIRAL ANTIGENS which can be measured by IMMUNOFLUORESCENCE. Bacteriophage Plaque Assay,Assay, Bacteriophage Plaque,Assay, Viral Plaque,Assays, Bacteriophage Plaque,Assays, Viral Plaque,Bacteriophage Plaque Assays,Plaque Assay, Bacteriophage,Plaque Assay, Viral,Plaque Assays, Bacteriophage,Plaque Assays, Viral,Viral Plaque Assays
D002482 Cellulose A polysaccharide with glucose units linked as in CELLOBIOSE. It is the chief constituent of plant fibers, cotton being the purest natural form of the substance. As a raw material, it forms the basis for many derivatives used in chromatography, ion exchange materials, explosives manufacturing, and pharmaceutical preparations. Alphacel,Avicel,Heweten,Polyanhydroglucuronic Acid,Rayophane,Sulfite Cellulose,alpha-Cellulose,Acid, Polyanhydroglucuronic,alpha Cellulose
D003362 Cost-Benefit Analysis A method of comparing the cost of a program with its expected benefits in dollars (or other currency). The benefit-to-cost ratio is a measure of total return expected per unit of money spent. This analysis generally excludes consideration of factors that are not measured ultimately in economic terms. In contrast a cost effectiveness in general compares cost with qualitative outcomes. Cost and Benefit,Cost-Benefit Data,Benefits and Costs,Cost Benefit,Cost Benefit Analysis,Cost-Utility Analysis,Costs and Benefits,Economic Evaluation,Marginal Analysis,Analyses, Cost Benefit,Analysis, Cost Benefit,Analysis, Cost-Benefit,Analysis, Cost-Utility,Analysis, Marginal,Benefit and Cost,Cost Benefit Analyses,Cost Benefit Data,Cost Utility Analysis,Cost-Benefit Analyses,Cost-Utility Analyses,Data, Cost-Benefit,Economic Evaluations,Evaluation, Economic,Marginal Analyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012685 Sepharose Agarose,Sepharose 4B,Sepharose C1 4B,4B, Sepharose C1,C1 4B, Sepharose
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D029322 Norovirus A genus in the family CALICIVIRIDAE, associated with epidemic GASTROENTERITIS in humans. The type species, NORWALK VIRUS, contains multiple strains. Norwalk-like Viruses,Small Round-Structured Viruses,Noroviruses,Norwalk like Viruses,Round-Structured Viruses, Small,Small Round Structured Viruses

Related Publications

Soh Yamamoto, and Yuka Sudo-Yokoyama, and Noriko Ogasawara, and Shin-Ichi Yokota
August 2012, Journal of visualized experiments : JoVE,
Soh Yamamoto, and Yuka Sudo-Yokoyama, and Noriko Ogasawara, and Shin-Ichi Yokota
May 2016, Carbohydrate polymers,
Soh Yamamoto, and Yuka Sudo-Yokoyama, and Noriko Ogasawara, and Shin-Ichi Yokota
January 2021, Science progress,
Soh Yamamoto, and Yuka Sudo-Yokoyama, and Noriko Ogasawara, and Shin-Ichi Yokota
September 2018, BioTechniques,
Soh Yamamoto, and Yuka Sudo-Yokoyama, and Noriko Ogasawara, and Shin-Ichi Yokota
May 2001, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
Soh Yamamoto, and Yuka Sudo-Yokoyama, and Noriko Ogasawara, and Shin-Ichi Yokota
January 2008, Applied and environmental microbiology,
Soh Yamamoto, and Yuka Sudo-Yokoyama, and Noriko Ogasawara, and Shin-Ichi Yokota
July 2017, Journal of immunological methods,
Soh Yamamoto, and Yuka Sudo-Yokoyama, and Noriko Ogasawara, and Shin-Ichi Yokota
January 2009, Plant methods,
Soh Yamamoto, and Yuka Sudo-Yokoyama, and Noriko Ogasawara, and Shin-Ichi Yokota
January 1977, Clinica chimica acta; international journal of clinical chemistry,
Soh Yamamoto, and Yuka Sudo-Yokoyama, and Noriko Ogasawara, and Shin-Ichi Yokota
October 1999, International journal of pharmaceutics,
Copied contents to your clipboard!